355 related articles for article (PubMed ID: 17437683)
1. Leukotriene synthesis inhibitors versus antagonists: the pros and cons.
Steinke JW; Culp JA
Curr Allergy Asthma Rep; 2007 May; 7(2):126-33. PubMed ID: 17437683
[TBL] [Abstract][Full Text] [Related]
2. Asthma therapy with agents preventing leukotriene synthesis or action.
Drazen JM
Proc Assoc Am Physicians; 1999; 111(6):547-59. PubMed ID: 10591083
[TBL] [Abstract][Full Text] [Related]
3. [The role of leukotrienes in inflammation and leukotriene inhibitors].
Kupczyk M; Kuna P
Pol Merkur Lekarski; 1999 Sep; 7(39):85-93. PubMed ID: 10598480
[TBL] [Abstract][Full Text] [Related]
4. [Leukotriene modifiers].
Minoguchi K; Adachi M
Nihon Rinsho; 2001 Oct; 59(10):1979-85. PubMed ID: 11676142
[TBL] [Abstract][Full Text] [Related]
5. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part I: synthesis, receptors and role of leukotrienes in asthma.
Devillier P; Baccard N; Advenier C
Pharmacol Res; 1999 Jul; 40(1):3-13. PubMed ID: 10378985
[TBL] [Abstract][Full Text] [Related]
6. The role of antileukotrienes in asthma management.
Tan RA
Curr Opin Pulm Med; 1998 Jan; 4(1):25-30. PubMed ID: 9526901
[TBL] [Abstract][Full Text] [Related]
7. Leukotriene Inhibitors in Sinusitis.
Steinke JW; Kennedy JL
Curr Infect Dis Rep; 2012 Jan; ():. PubMed ID: 22286339
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthma.
Bisgaard H
Allergy; 2001; 56 Suppl 66():7-11. PubMed ID: 11421935
[TBL] [Abstract][Full Text] [Related]
9. Leukotrienes, antileukotrienes and asthma.
Montuschi P
Mini Rev Med Chem; 2008 Jun; 8(7):647-56. PubMed ID: 18537720
[TBL] [Abstract][Full Text] [Related]
10. Cysteinyl leukotrienes in asthma: old mediators up to new tricks.
Hay DW; Torphy TJ; Undem BJ
Trends Pharmacol Sci; 1995 Sep; 16(9):304-9. PubMed ID: 7482995
[TBL] [Abstract][Full Text] [Related]
11. Leukotriene modifiers. Expanded role may be on horizon.
Hayden ML
Adv Nurse Pract; 2000 Oct; 8(10):42-6. PubMed ID: 11761536
[No Abstract] [Full Text] [Related]
12. Leukotrienes in respiratory disease.
McMillan RM
Paediatr Respir Rev; 2001 Sep; 2(3):238-44. PubMed ID: 12052325
[TBL] [Abstract][Full Text] [Related]
13. Leukotriene modifiers in pediatric asthma management.
Bisgaard H
Pediatrics; 2001 Feb; 107(2):381-90. PubMed ID: 11158473
[TBL] [Abstract][Full Text] [Related]
14. Leukotrienes in asthma. The potential therapeutic role of antileukotriene agents.
Smith LJ
Arch Intern Med; 1996 Oct; 156(19):2181-9. PubMed ID: 8885816
[TBL] [Abstract][Full Text] [Related]
15. Leukotriene modifiers: new drugs, old and new reactions.
Rosenwasser LJ
J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):374-5. PubMed ID: 10069868
[No Abstract] [Full Text] [Related]
16. Antileukotriene treatment in children with asthma--new patents.
Stelmach I; Grzelewski T
Recent Pat Inflamm Allergy Drug Discov; 2008 Nov; 2(3):202-11. PubMed ID: 19076010
[TBL] [Abstract][Full Text] [Related]
17. Leukotriene receptor antagonists and related compounds.
Wenzel SE
Can Respir J; 1999; 6(2):189-93. PubMed ID: 10322101
[TBL] [Abstract][Full Text] [Related]
18. Leukotriene pathway genetics and pharmacogenetics in allergy.
Duroudier NP; Tulah AS; Sayers I
Allergy; 2009 Jun; 64(6):823-39. PubMed ID: 19416143
[TBL] [Abstract][Full Text] [Related]
19. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
Muz MH; Deveci F; Bulut Y; Ilhan N; Yekeler H; Turgut T
Exp Mol Med; 2006 Apr; 38(2):109-18. PubMed ID: 16672764
[TBL] [Abstract][Full Text] [Related]
20. Cysteinyl leukotriene receptor-1 antagonists as modulators of innate immune cell function.
Theron AJ; Steel HC; Tintinger GR; Gravett CM; Anderson R; Feldman C
J Immunol Res; 2014; 2014():608930. PubMed ID: 24971371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
